help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Published ahead of print on April 7, 2004, doi:10.1164/rccm.200309-1304OC

Am. J. Respir. Crit. Care Med., Volume 170, Number 2, July 2004, 148-153

A more recent version of this article appeared on July 15, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200309-1304OCv1
170/2/148    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morris, C. R
Right arrow Articles by Morris, Jr., S. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morris, C. R
Right arrow Articles by Morris, Jr., S. M

Submitted on September 29, 2003
Accepted on April 3, 2004

Decreased Arginine Bioavailability and Increased Serum Arginase Activity in Asthma

Claudia R Morris1*, Mirjana Poljakovic2, Lisa Lavrisha3, Lorenzo Machado4, Frans A Kuypers4, and Sidney M Morris, Jr.2

1 Department of Emergency Medicine, Children's Hospital and Research Center at Oakland, Oakland, CA, USA, 2 Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA, 3 Pediatric Clinical Research Center, Chidren's Hospital and Research Center at Oakland, Oakland, CA, USA, 4 Children's Hospital Oakland Research Institute, Oakland, CA, USA

* To whom correspondence should be addressed. E-mail: claudiamorris{at}comcast.net.

Recent studies suggest that a nitric oxide deficiency and elevated arginase activity may play a role in the pathogenesis of asthma. Although much attention has been directed towards measurements of exhaled nitric oxide in asthma, no studies to date have evaluated levels of plasma arginase or arginine, the substrate for nitric oxide production, in asthmatic patients. This study therefore measured amino acid levels, arginase activity, and nitric oxide metabolites in the blood of asthmatic patients, as well as nitric oxide in exhaled breath. Although levels of virtually all amino acids were reduced, asthmatic patients exhibited a striking reduction in plasma arginine levels compared to non-asthmatic normal controls (45 ± 22 vs. 94 ± 29 µM, p < 0.0001), and serum arginase activity was elevated (1.6 ± 0.8 vs. 0.5 ± 0.3 µmol/ml/hr, asthma vs. control, p < 0.0001). High arginase activity in asthmatic patients may contribute to low circulating arginine levels, thereby limiting arginine bioavailability and creating a nitric oxide deficiency that induces hyperreactive airways. Addressing the alterations in arginine metabolism may result in new strategies for treatment of asthma.
Key words: asthmatic, L-arginine, amino acids, nitric oxide, nitric oxide synthase




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
J. E. MacLean, E. Atenafu, M. Kirby-Allen, I. B. MacLusky, D. Stephens, H. Grasemann, and P. Subbarao
Longitudinal Decline in Lung Volume in a Population of Children with Sickle Cell Disease
Am. J. Respir. Crit. Care Med., November 15, 2008; 178(10): 1055 - 1059.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
L. Santhanam, D. W. Christianson, D. Nyhan, and D. E. Berkowitz
Arginase and vascular aging
J Appl Physiol, November 1, 2008; 105(5): 1632 - 1642.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Lara, S. B. Khatri, Z. Wang, S. A. A. Comhair, W. Xu, R. A. Dweik, M. Bodine, B. S. Levison, J. Hammel, E. Bleecker, et al.
Alterations of the Arginine Metabolome in Asthma
Am. J. Respir. Crit. Care Med., October 1, 2008; 178(7): 673 - 681.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. Maarsingh, A. B. Zuidhof, I. S. T. Bos, M. van Duin, J.-L. Boucher, J. Zaagsma, and H. Meurs
Arginase Inhibition Protects against Allergen-induced Airway Obstruction, Hyperresponsiveness, and Inflammation
Am. J. Respir. Crit. Care Med., September 15, 2008; 178(6): 565 - 573.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
H. Meurs, R. Gosens, and J. Zaagsma
Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models
Eur. Respir. J., August 1, 2008; 32(2): 487 - 502.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. Ryoo, G. Gupta, A. Benjo, H. K. Lim, A. Camara, G. Sikka, H. K. Lim, J. Sohi, L. Santhanam, K. Soucy, et al.
Endothelial Arginase II: A Novel Target for the Treatment of Atherosclerosis
Circ. Res., April 25, 2008; 102(8): 923 - 932.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
C. Grasemann, F. Ratjen, D. Schnabel, E. Reutershahn, U. Vester, and H. Grasemann
Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients
Eur. Respir. J., April 1, 2008; 31(4): 815 - 821.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Tiso, A. Strub, C. Hesslinger, C. T. Kenney, R. Boer, and D. J. Stuehr
BYK191023 (2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine) Is an NADPH- and Time-Dependent Irreversible Inhibitor of Inducible Nitric-Oxide Synthase
Mol. Pharmacol., April 1, 2008; 73(4): 1244 - 1253.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Belik, D. Shehnaz, J. Pan, and H. Grasemann
Developmental changes in arginase expression and activity in the lung
Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L498 - L504.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. C. Lewis, J. Y. H. Yang, X. Huang, S. K. Banerjee, M. R. Blackburn, P. Baluk, D. M. McDonald, T. S. Blackwell, V. Nagabhushanam, W. Peters, et al.
Disease-Specific Gene Expression Profiling in Multiple Models of Lung Disease
Am. J. Respir. Crit. Care Med., February 15, 2008; 177(4): 376 - 387.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
C. R. Morris
Mechanisms of Vasculopathy in Sickle Cell Disease and Thalassemia
Hematology, January 1, 2008; 2008(1): 177 - 185.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. Takemoto, K. Ogino, M. Shibamori, T. Gondo, Y. Hitomi, T. Takigawa, D.-H. Wang, J. Takaki, H. Ichimura, Y. Fujikura, et al.
Transiently, paralleled upregulation of arginase and nitric oxide synthase and the effect of both enzymes on the pathology of asthma
Am J Physiol Lung Cell Mol Physiol, December 1, 2007; 293(6): L1419 - L1426.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. J. Nicholls, Z. Wang, R. Koeth, B. Levison, B. DelFraino, V. Dzavik, O. W. Griffith, D. Hathaway, J. A. Panza, S. E. Nissen, et al.
Metabolic Profiling of Arginine and Nitric Oxide Pathways Predicts Hemodynamic Abnormalities and Mortality in Patients With Cardiogenic Shock After Acute Myocardial Infarction
Circulation, November 13, 2007; 116(20): 2315 - 2324.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
D. A van Waardenburg, C. T de Betue, Y. C Luiking, M. Engel, and N. E Deutz
Plasma arginine and citrulline concentrations in critically ill children: strong relation with inflammation
Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1438 - 1444.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. B. Sopi, M. A. Haxhiu, R. J. Martin, I. A. Dreshaj, S. Kamath, and S. I. A. Zaidi
Disruption of NO-cGMP signaling by neonatal hyperoxia impairs relaxation of lung parenchyma
Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L1029 - L1036.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M. E. Brosnan and J. T. Brosnan
Orotic Acid Excretion and Arginine Metabolism
J. Nutr., June 1, 2007; 137(6): 1656S - 1661S.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. T. Quinn, E. P. Shull, N. Ahmad, N. J. Lee, Z. R. Rogers, and G. R. Buchanan
Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia
Blood, January 1, 2007; 109(1): 40 - 45.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
J. S. Siegle, N. Hansbro, C. Herbert, M. Yang, P. S. Foster, and R. K. Kumar
Airway Hyperreactivity in Exacerbation of Chronic Asthma Is Independent of Eosinophilic Inflammation
Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 565 - 570.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
B. J. Canning
Reflex regulation of airway smooth muscle tone
J Appl Physiol, September 1, 2006; 101(3): 971 - 985.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. Grasemann, F. Kurtz, and F. Ratjen
Inhaled L-Arginine Improves Exhaled Nitric Oxide and Pulmonary Function in Patients with Cystic Fibrosis
Am. J. Respir. Crit. Care Med., July 15, 2006; 174(2): 208 - 212.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. E. Korf, G. Pynaert, K. Tournoy, T. Boonefaes, A. Van Oosterhout, D. Ginneberge, A. Haegeman, J. A. Verschoor, P. De Baetselier, and J. Grooten
Macrophage Reprogramming by Mycolic Acid Promotes a Tolerogenic Response in Experimental Asthma
Am. J. Respir. Crit. Care Med., July 15, 2006; 174(2): 152 - 160.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
H. Post and B. Pieske
Arginase: a modulator of myocardial function
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1747 - H1748.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Erdely, D. Kepka-Lenhart, M. Clark, P. Zeidler-Erdely, M. Poljakovic, W. J. Calhoun, and S. M. Morris Jr
Inhibition of phosphodiesterase 4 amplifies cytokine-dependent induction of arginase in macrophages
Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L534 - L539.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. Grasemann, R. Schwiertz, S. Matthiesen, K. Racke, and F. Ratjen
Increased Arginase Activity in Cystic Fibrosis Airways
Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1523 - 1528.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Di Costanzo, G. Sabio, A. Mora, P. C. Rodriguez, A. C. Ochoa, F. Centeno, and D. W. Christianson
Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response
PNAS, September 13, 2005; 102(37): 13058 - 13063.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
F. Perticone, A. Sciacqua, R. Maio, M. Perticone, R. Maas, R. H. Boger, G. Tripepi, G. Sesti, and C. Zoccali
Asymmetric Dimethylarginine, L-Arginine, and Endothelial Dysfunction in Essential Hypertension
J. Am. Coll. Cardiol., August 2, 2005; 46(3): 518 - 523.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
C. R. Morris, G. J. Kato, M. Poljakovic, X. Wang, W. C. Blackwelder, V. Sachdev, S. L. Hazen, E. P. Vichinsky, S. M. Morris Jr, and M. T. Gladwin
Dysregulated Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension, and Mortality in Sickle Cell Disease
JAMA, July 6, 2005; 294(1): 81 - 90.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. Fabbri, S. P. Peters, I. Pavord, S. E. Wenzel, S. C. Lazarus, W. MacNee, F. Lemaire, and E. Abraham
Allergic Rhinitis, Asthma, Airway Biology, and Chronic Obstructive Pulmonary Disease in AJRCCM in 2004
Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 686 - 698.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
H. Grasemann, C. Grasemann, F. Kurtz, G. Tietze-Schillings, U. Vester, and F. Ratjen
Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study
Eur. Respir. J., January 1, 2005; 25(1): 62 - 68.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2004 American Thoracic Society 		  ATS Sleep Tracings Quiz